In their study, Maldonado, and colleagues utilized the NASH Clinical Research Network to examine the relationship between AMH concentrations and histological outcomes of NAFLD in 205 premenopausal women, 20% of whom had PCOS. The gene discussed is AMH; the disease is metabolic dysfunction-associated steatohepatitis.